Evidence map›Paper›PMID 37047497›Full record

ArticleInternational journal of molecular sciences2023

Targeted Blood Plasma Proteomics and Hemostasis Assessment of Post COVID-19 Patients with Acute Myocardial Infarction.

Anna Kalinskaya, Daria Vorobyeva, George Rusakovich, Elena Maryukhnich, Alexandra Anisimova, Oleg Dukhin, Antonina Elizarova, Oxana Ivanova, Anna Bugrova, Alexander Brzhozovskiy and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Anna KalinskayaLaboratory of Atherothrombosis, Cardiology Department, A.I. Evdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia.ORCID 0000-0003-2316-4238
Daria VorobyevaLaboratory of Atherothrombosis, Cardiology Department, A.I. Evdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia.
George RusakovichI.V. Davydovsky Moscow City Clinical Hospital, Moscow Department of Healthcare, 117463 Moscow, Russia.ORCID 0000-0001-7577-704X
Elena MaryukhnichLaboratory of Atherothrombosis, Cardiology Department, A.I. Evdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia.
Alexandra AnisimovaI.V. Davydovsky Moscow City Clinical Hospital, Moscow Department of Healthcare, 117463 Moscow, Russia.
Oleg DukhinI.V. Davydovsky Moscow City Clinical Hospital, Moscow Department of Healthcare, 117463 Moscow, Russia.
Antonina ElizarovaI.V. Davydovsky Moscow City Clinical Hospital, Moscow Department of Healthcare, 117463 Moscow, Russia.
Oxana IvanovaLaboratory of Atherothrombosis, Cardiology Department, A.I. Evdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia.
Anna BugrovaEmanuel Institute for Biochemical Physics, Russian Academy of Science, 119991 Moscow, Russia.ORCID 0000-0003-1515-9447
Alexander BrzhozovskiyCenter for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.
Alexey KononikhinCenter for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.
Evgeny NikolaevCenter for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.ORCID 0000-0001-6209-2068
Elena VasilievaLaboratory of Atherothrombosis, Cardiology Department, A.I. Evdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia.ORCID 0000-0003-4111-0874
Moscow State University of Medicine and Dentistry · RUCity Clinical Hospital · RUSkolkovo Institute of Science and Technology · RU

Funding

Moscow Government 2312-44/22
6 · The paper itself

Abstract

The molecular mechanisms underlying cardiovascular complications after the SARS-CoV-2 infection remain unknown. The goal of our study was to analyze the features of blood coagulation, platelet aggregation, and plasma proteomics in COVID-19 convalescents with AMI. The study included 66 AMI patients and 58 healthy volunteers. The groups were divided according to the anti-N IgG levels (AMI post-COVID (

Indexed as

COVID-19Myocardial InfarctionHemostasisHumansInflammationPlasmaProteomicsSARS-CoV-2acute myocardial infarctionCOVID-19hemostasispost-COVIDproteomics analysisSARS-CoV-2

Identifiers

PMID37047497
PMCPMC10094800
OpenAlexW4362471305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.